Blog
How to select sensitive outcome measures in pro-cognitive drug trials for schizophrenia
The outcome measure selected for a pro-cognitive drug trial in schizophrenia must be sensitive enough to detect potentially subtle changes in cognition.
Evolocumab Phase 3 Cognitive Function Study Results Published in the New England Journal of Medicine
Cambridge Cognition and Amgen announce that the New England Journal of Medicine (NEJM) published results from the evolocumab cognitive function trial, which was conducted in a subset of patients enrolled in the randomized, placebo-controlled evolocumab cardiovascular outcomes study.
web-based testing,
wearables,
virtual clinical trials,
technology,
swm,
stigma,
social cognition,
smartphones,
schizophrenia research,
schizophrenia,
safety,
research funding,
research,
remote testing,
regulations,
recruitment,
rare disease,
psychosis,
prodromal,
pro-cognitive,
press release,
presenteeism,
precision psychiatry,
pre-clinical,
poster,
personalised medicine,
patient-centric,
patient recruitment,
parkinson's disease,
pal,
paired associates learning,
ots,
occupational health,
normative data,
neurotech,
neuroscience,
near-patient testing,
multiple sclerosis,
ms,
modelling,
mental wellbeing,
mental health at work,
mental health,
mdd,
mci,
major depression,
longitudinal,
ied,
high-frequency testing,
high frequency,
healthcare,
grant,
funding,
fatigue,
ert,
epidemiology,
emotion recognition,
ecoa,
ebt,
ebbinghaus,
early career researchers,
early alzheimer's disease,
drug development,
digital tools,
digital health,
depression,
dementia,
cognitive testing,
cognitive science,
cognitive safety,
cognitive impairment,
cognitive function,
cognitive dysfunction,
cognitive biomarkers,
cognitive assessment,
cognition kit,
cognition,
cns summit,
clinical trials,
cias,
chronic illness,
chronic health conditions,
cgt,
cantab testimonial,
cantab research grant,
cantab for clinical trials,
cantab,
brain health,
biomarkers,
awards,
automatic speech recognition,
autism,
attention,
asr,
asd,
alzheimer's disease,
affective cognition,
adolescents,
absenteeism,
aaic,
